Venture Capital

Verve Ventures

Investment Details

Investor Type
Venture Capital

Asset Class Focus
Venture Capital

Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Pre-Seed

Geographical Focus
United States, United Kingdom, Finland

Industries Focus

  • Technology
  • Healthcare
  • Artificial Intelligence
  • Machine Learning
  • Mobility
  • Natural Language Processing
  • Science
  • Health & Bio

Investor Details Founded: 2018

Verve Ventures is a network and technology-driven venture capital firm headquartered in London, United Kingdom. Founded in 2018, the firm focuses on investing in early-stage science and technology startups across the United States and the United Kingdom. Verve Ventures aims to support entrepreneurs by providing funding and guidance to help them scale their innovative businesses.

The firm's investment strategy encompasses various stages, including Pre-Seed, Seed, Series A, and Series B, with a minimum investment size of €3 million. Verve Ventures primarily targets sectors such as Technology, Science, and Health & Bio, reflecting its commitment to fostering advancements in these fields.

With a pan-European network of selected private and institutional investors, Verve Ventures offers access to top-tier investment opportunities, leveraging its extensive industry connections and expertise to identify and support promising startups.

Requirements
  • Innovative technology solutions
  • Scalable business models
  • Strong founding teams
  • Early-stage science and technology startups
  • Innovative business models
  • Scalable growth potential
Contact

[Official Website Hidden]

[LinkedIn Profile Hidden]

[HQ Location Hidden]

[Email Hidden]

[Contact Number Hidden]

Portfolio Companies
  • Memo Therapeutics AG
  • Axelera
  • Neustark
  • tozero
  • Sympatient
  • 9T Labs
  • Pregnolia
  • Beekeeper
Claim this Investor

Are you an official representative of Verve Ventures?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim